TV 목록 보기
증권
지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
[PRNewswire] Merck Announces Out-Licensing Agreement for Phase II-ready 2020-10-06 21:25:23
[PRNewswire] Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis - Merck out-licenses promising clinical-stage program to Novartis - Anti-ADAMTS5 Nanobody(R) program is Phase II-ready with novel MoA which could protect against cartilage damage and...
[PRNewswire] Merck Announces Positive Phase II Results for Investigational 2020-09-10 21:08:46
[PRNewswire] Merck Announces Positive Phase II Results for Investigational Sonelokinab (M1095) in Patients with Moderate to Severe Chronic Plaque-Type Psoriasis - Not intended for UK and US based media - Sonelokinab is an investigational IL-17 A/F Nanobody (R) , which neutralizes both IL-17A and...
[PRNewswire] 머크, 5천900만 유로 투자로 항체 의약품 포합 물질 제조 시설 확장 2020-09-10 00:43:52
- https://mma.prnewswire.com/media/1250213/Merck_ADC_Expansion.jpg Merck is expanding its ADC manufacturing capabilities. ADCs are an emerging class of medicines designed for high-specificity targeting and destruction of cancer cells, while preserving healthy ones. 출처: 머크(Merck) Merck Announces...
[PRNewswire] QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to 2020-05-19 20:37:30
preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics. QPS announces an expanded and upgraded fleet of high-resolution mass spectrometers (HRMS), with the addition of three new TripleTOF(R) [https://sciex.com/...
[PRNewswire] Genome & Company announces a clinical trial collaboration and 2020-01-14 09:06:44
Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer -- Clinical partnership of phase 1/1b combination clinical trial with Genome & Company's GEN-001, microbiome-based immuno-oncology therapy, and avelumab (BAVENCIO(R)), Merck KGaA,...
[PRNewswire] Merck Announces Orphan Drug Designation for Investigational 2019-11-20 16:07:41
[PRNewswire] Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations - Japanese Ministry of Health, Labour and Welfare grants orphan drug designation for diseases that affect fewer than 50,000 patients in Japan, and for...
[PRNewswire] Merck Announces FDA Breakthrough Therapy Designation for 2019-09-11 15:49:12
[PRNewswire] Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations - Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET...
[PRNewswire] Pneuma Respiratory, Inc. Announces New Chairman of the Board 2019-08-22 10:44:39
[PRNewswire] Pneuma Respiratory, Inc. Announces New Chairman of the Board (BOONE, North Carolina, Aug. 21, 2019 PRNewswire=연합뉴스) Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will...
[ 분야별 송고기사 LIST ]-외신 2019-05-16 08:00:07
2019 Chinese Artisan Food Festival에서 빛나는 시안 요리 190515-0888 외신-012316:03 [PRNewswire] Comscore Announces New Leadership in APAC and EMEA 190515-0890 외신-012416:04 호주, 극심한 가뭄에 곡물 생산 '비상'…12년 만에 밀 수입 190515-0891 외신-012516:04 페북에 혐오·테러 영상 올리면...
[PRNewswire] Tessa Therapeutics Announces Collaboration with MSD Investigating 2019-04-16 09:51:17
[PRNewswire] Tessa Therapeutics Announces Collaboration with MSD Investigating the Combination of KEYTRUDA(R) (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer - The collaboration will evaluate the safety and efficacy of Tessa's armored human...
TV 목록 보기
증권
